« Previous
Next »
Journal of the American Society of Hypertension
Volume 2, Issue 3
, Pages 140-151
, May 2008
Beyond blood pressure: Arterial stiffness as a new biomarker of cardiovascular disease
References
- European Network for Non-invasive Investigation of Large Arteries (Expert consensus document on arterial stiffness: methodological issues and clinical applications). Eur Heart J. 2006;27:2588–2605
- Central blood pressure measurements and antihypertensive therapy. Hypertension. 2007;50:154–160
- National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. [Erratum in 2003;290:197] JAMA. 2003;289:2560–2572
- 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462–1536
- . Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Hypertension. 2001;37:869–874
- Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997;96:308–315
- Franklin SS, Wilkinson IB, Cockcroft JR. Brachial and central pulse pressure, and cardiovascular risk. In: Safar ME, O'Rourke MF, editors. Handbook of hypertension. Volume 23 Arterial stiffness in hypertension. London, England: Elsevier, p. 225–40.
- . McDonald's blood flow in arteries: theoretical, experimental and clinical principles. 5th ed.. London, England: Hodder Arnold; 2005;
- . Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932–943
- Does the relation of blood pressure to coronary heart disease risk change with aging? (The Framingham Heart Study). Circulation. 2001;103:1245–1249
- . Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation. 2001;104:783–789
- . Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. Eur Heart J. 2005;26:2120–2126
- . Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension. 1998;32:983–988
- . Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753–1760
- Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
- . Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932–937
- . Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses. Hypertension. 2003;42:150–155
- . Noninvasive determination of aortic input impedance and external left ventricular power output: a validation repeatability study of a new technique. J Am Coll Cardiol. 1992;20:952–963
- Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735–738
- . Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens. 2004;22:1937–1944
- . Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens. 1995;13:943–952
- . Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434–438
- Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation. 2002;105:1202–1207
- . Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17:118–123
- Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38:429–433
- Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes. Hypertension. 2004;44:67–71
- . C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol. 2004;24:969–974
- Inflammation and arterial stiffness in systemic vasculitis, a model of vascular inflammation. Arthritis Rheum. 2004;50:581–588
- Arterial stiffness in chronic inflammatory diseases. Hypertension. 2005;46:194–199
- . Wave reflections and cardiac hypertrophy in chronic uremia (Influence of body size). Hypertension. 1993;22:876–883
- Age-specific relationship of aortic pulse wave velocity with left ventricular geometry and function in hypertension. Hypertension. 2007;49:317–321
- . Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure. Am J Hypertens. 2007;20:378–384
- Aortic stiffness is associated with atherosclerosis of the coronary arteries in older adults: the Rotterdam Study. J Hypertens. 2006;24:2371–2376
- Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke. 2005;36:2193–2197
- . Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens. 2007;25:1035–1040
- . Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens. 2007;25:1035–1040
- . Increased aortic stiffness: an unfavorable cardiorenal connection. Hypertension. 2004;43:151–153
- . Chronic kidney disease, effects on the cardiovascular system. Circulation. 2007;116:85–97
- Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int. 2006;69:350–357
- . Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439
- . Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol. 2001;21:2046–2050
- . Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation. 2002;106:2085–2090
- Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15
- Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203–1206
- Health ABC Study (Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults). Circulation. 2005;111:3384–3390
- Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657–663
- Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664–670
- . Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty. Circulation. 2000;101:470–472
- Pulsatility of ascending aorta and restenosis after coronary angioplasty in patients >60 years of age with stable angina pectoris. Am J Cardiol. 2001;88:964–968
- Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007;50:197–203
- CAFE Investigators, Anglo-Scandinavian Cardiac Outcomes Trial Investigators, CAFE Steering Committee and Writing Committee (Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) Study). Circulation. 2006;113:1213–1225
- Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109:184–189
- . The timing of the reflected wave in the ascending aortic pressure predicts restenosis after coronary stent placement. Hypertens Res. 2004;27:535–540
- Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension. 2005;45:980–985
- Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension. 2006;47:785–790
- Noninvasive (input) impedance, pulse wave velocity, and wave reflection in healthy middle-aged men and women. Hypertension. 2007;49:1248–1255
- . Blood pressure lowering treatment trialists' collaboration, effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet. 2003;362:1527–1535
- Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension. 2005;46:386–392
- . Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery?. [Erratum in 2005;23:903–4] J Hypertens. 2005;23:551–556
- . Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure. J Hypertens. 2007;25:1095–1099
- Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension. 2006;48:80–86
- LIFE Study Group (Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol). Lancet. 2002;359:995–1003
- . Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens. 2006;19:214–219
- . Mechanism(s) of selective systolic blood pressure reduction after a low–dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92–99
- . Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623–1630
Dr. Franklin is on the Speakers Bureau for Boehringer Ingelheim, Bristol-Myers Squibb, and Merck, and a Consultant for AtCor Medical, and Bristol-Myers Squibb.
PII: S1933-1711(07)00194-5
doi: 10.1016/j.jash.2007.09.002
© 2008 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of the American Society of Hypertension
Volume 2, Issue 3
, Pages 140-151
, May 2008
